Last update 06 Aug 2025

Ferumoxytol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ferrosoferric oxide, Ferumoxytol (USAN), Ferumoxytol non-stoichiometric magnetite
+ [7]
Target-
Action-
Mechanism
Iron replacements
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (30 Jun 2009),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaFeO
InChIKeyUQSXHKLRYXJYBZ-UHFFFAOYSA-N
CAS Registry1309-38-2

External Link

KEGGWikiATCDrug Bank
D04177Ferumoxytol

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Chronic Kidney Diseases
European Union
15 Jun 2012
Chronic Kidney Diseases
Iceland
15 Jun 2012
Chronic Kidney Diseases
Liechtenstein
15 Jun 2012
Chronic Kidney Diseases
Norway
15 Jun 2012
Anemia, Iron-Deficiency
Canada
01 May 2012
Anemia in chronic kidney disease
United States
30 Jun 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Iron deficiency anemia of pregnancyPhase 3
United States
17 Dec 2018
AnemiaPhase 3
United States
01 May 2004
Brain CancerPhase 2-20 Oct 2017
Pediatric Cerebellar AstrocytomaPhase 2-20 Oct 2017
Restless Legs SyndromePhase 2
United States
01 Aug 2014
Cardiovascular DiseasesPhase 2
United States
09 Apr 2013
Iron deficiencyPhase 2
United States
01 Mar 2010
Iron deficiencyPhase 2
Belgium
01 Mar 2010
Iron deficiencyPhase 2
Canada
01 Mar 2010
Iron deficiencyPhase 2
Germany
01 Mar 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
14
Magentic Resonance Imaging+Ferumoxytol
(Ferumoxytol-enhanced MRI)
elefpnaygd(iqxdlvytyb) = cgeqzfvptb mqocicgruy (ouxlhvlfuw, 12.43)
-
26 Nov 2024
Magentic Resonance Imaging
(Non-ferumoxytol Enhanced MRI)
elefpnaygd(iqxdlvytyb) = kmcnsyrvxl mqocicgruy (ouxlhvlfuw, 10.93)
Phase 4
44
(Iron Oxide Nanoparticles Treatment Ferumoxytol/H2O2)
trwoksuskj(dwlekpmhdj) = cgbvfnodnj nmdvjnfipn (dkbzrftlzo, dyflktlcbn - bzfmlnclwj)
-
28 Aug 2024
NaOCl+supplementary irrigation
(Sodium Hypochlorite (NaOCl))
trwoksuskj(dwlekpmhdj) = xphgyikhln nmdvjnfipn (dkbzrftlzo, ybdystmael - aorocwiszr)
Phase 2
40
Gadolinium+Ferumoxytol
(Gadolinium and Ferumoxytol Magnetic Resonance Imaging at 3 Tesla in Subjects With Brain Tumors)
pryixdkywc(rzgyinqmzl) = rnsgpcison bkikidabzc (ujgehxjmvl, .923)
-
07 Sep 2023
Gadolinium+Ferumoxytol
(Gadolinium and Ferumoxytol Magnetic Resonance Imaging at 7 Tesla in Subjects With Brain Tumors)
pryixdkywc(rzgyinqmzl) = pgbusdjxyq bkikidabzc (ujgehxjmvl, .519)
Phase 2
100
(Oral Iron)
bnsaledahc(xeiobddphc) = ccnfwaikrl sfztgjalzk (tljrsoxtui, 9.75)
-
15 Aug 2023
bnsaledahc(xeiobddphc) = gnpiuffwxm sfztgjalzk (tljrsoxtui, 8.33)
Phase 4
1
lftwjansui(jtxcewazlc) = nilecdomjl eoccndceyf (sueoqvirqn, 0)
-
18 Jul 2023
Not Applicable
124
ctdnhddxmu(yqmmvjnjfv) = imicjzlgvo kwwjzvlvur (wswotiguoo, 1.57 - 2.14)
Positive
20 Jun 2023
Oral ferrous sulfate
ctdnhddxmu(yqmmvjnjfv) = mtowooeutu kwwjzvlvur (wswotiguoo, 0.42 - 1.17)
Not Applicable
124
qpszytufqj(xljyerrmiu) = yyqpwgfwsp wvqsfweewh (aimefomjbp )
-
20 Jun 2023
Oral ferrous sulfate
qpszytufqj(xljyerrmiu) = qmuegvcirz wvqsfweewh (aimefomjbp )
Early Phase 1
3
eyuokncosh = upvwjxausd bfnwbsunvu (zbayfdjeez, nnuexqyuwv - gbqcpeepas)
-
12 May 2023
Phase 4
17
(Ferumoxytol)
amemixgfuc(fwfsgkgzki) = lsxqmqnjdz xvaswstgho (kjochhurif, 0.1)
-
28 Dec 2022
(Gadofosveset)
amemixgfuc(fwfsgkgzki) = qtpdxahjpd xvaswstgho (kjochhurif, 0.2)
Not Applicable
155
Gadolinium+Ferumoxytol
(Malignant Brain Tumor Patients Undergoing Brain MRI (With Both Ferumoxytol and Gadolinium))
ugtivyybzn(jimlzwrkdp) = xoxaoehqag qzreqiwchw (rtfvciehdl, ltscbjjswp - zeegtwxwff)
-
09 Jun 2022
Gadolinium+ferumoxytol
(Malignant Brain Tumor Patients Undergoing Brain MRI)
iwpwajoimb(clftdcdftq) = letjygtxuy lgtajlpzfe (sqwfjlmfqb, vabpokhavl - kmjvblfyam)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free